• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Hemispherx Biopharma Inc

+ Add to Watchlist

HEB:US

0.3200 USD 0.0053 1.63%

As of 16:15:08 ET on 04/17/2014.

Company Profile for Hemispherx Biopharma Inc (HEB)

Hemispherx Biopharma, Inc. is a biopharmaceutical company that focuses on the development of nucleic acids to enhance the natural anti-viral defense systems of the human body. The Company's lead product, Ampligen, is undergoing clinical trials for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Contact Information

Hemispherx Biopharma Inc

1617 JFK Boulevard
Suite 660
Philadelphia, PA 19103
United States
Phone: 1-215-988-0080
Fax: 1-215-988-1739

Key Executives for Hemispherx Biopharma Inc (HEB)

William A CarterChairman/Pres/CEO/Chief Scientific OfcrThomas K EquelsVice Chair/CFO/Secy/Gen Cnsl
David R StrayerChief Medical Ofcr/Medical DirAdam PascaleChief Acctg Officer/Controller
Wayne S SpringateSenior VP:OperationsRalph Christopher CavalliVP:Quality Control

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil